Our Licensees

iPS Academia Japan grants licenses to over 250 domestic and international entities, encompassing both for-profit and not-for-profit organizations in the pharmaceutical (including biotechnology), reagent, chemical, food and cosmetic, custom service, medical device, and laboratory instrument industries. Our track record of these agreements signifies the crucial role that we have consistently played over the years in facilitating collaboration between academia and industry. We aspire to contribute to the realization of future breakthroughs in induced pluripotent stem cell (iPSC) technologies through licensing activities related to both, basic patents and application patents in the ever-evolving iPSC field.

  • Japan

    125

  • North America

    93

  • Europe

    58

  • Asia

    12

Numbers of our Licensees

iPS Academia Japan holds patent license agreements with over 250 entities, including both for-profit and not-for-profit organizations in a broad range of sectors.

Licensees by Industry

The successful negotiation of license agreements with various companies for research and development, and the commercialization of iPS cells demonstrates the continued growth and expansion of this field.

  1. Pharmaceutical

    44%

  2. Reagents

    22%

  3. Food/Chemical industry

    14%

  4. Research services

    8%

  5. Research instruments

    7%

  6. Other

    5%

List of licensees with the commercial agreement

  • ABS Biotechnologies
  • ACEL, Inc.
  • aceRNA Technologies Co., Ltd.
  • ACROBiosystems Inc.
  • Alstem, LLC
  • Anatomic Incorporated
  • Applied StemCell, Inc.
  • Axcelead Drug Discover Parthers, Inc.
  • Axol Bioscience Limited
  • Axxam S.p.A.
  • Bit Bio Limited
  • BPS Bioscience, Inc.
  • BrainXell, Inc.
  • BrainZell
  • Catalent Dusseldorf GmbH
  • Cell Pro Japan Co., Ltd.
  • Cellartgen Inc.
  • Cellectricon AB
  • Curi Bio, Inc.
  • Cytochroma Limited
  • Dai Nippon Printing Co., Ltd.
  • DiNABIOS
  • EditCo Bio,Inc.
  • ElevateBio
  • EMD MILLIPORE CORPORATION　
  • FUJIFILM Corporation
  • FUJIFILM Wako Pure Chemical Corporation
  • HEALIOS K.K.
  • HeartBeat.bio AG
  • I Peace, Inc.
  • Institute of Immunology Co., Ltd.
  • iPS Portal, Inc
  • IRBM Science Park S.p.A.
  • iXCells Biotechnologies USA, Inc.
  • Kurabo Industries Ltd.
  • Labcorp
  • Life & Brain GmbH
  • Locus Cell Co., Ltd.
  • MiCAN Technologies Inc.
  • Mitotype Precision Labs Ltd
  • Myoridge Co. Ltd.
  • myriamed GmbH
  • Ncardia Holdings SA
  • NeuCyte, Inc
  • NEXEL Co., Ltd.
  • Plurexa
  • Propria Inc.
  • Rege Nephro Co., Ltd.
  • Regenerative Medical Solutions, Inc.
  • Revvity Discovery Limited
  • Ricoh Biosciences, Inc.
  • Roslin Technologies Limited
  • SINFONIA TECHNOLOGY CO., Ltd.
  • Sparkling Sciences Co., Ltd.
  • Stem Cell & Device Laboratory, Inc
  • Stemnovate Limited
  • T&R Biofab Co., Ltd.
  • Takara Bio Inc.
  • TissUse GmbH
  • TOKIWA Bio Inc.
  • Trailhead Biosystems
  • UNITECH Co., Ltd.
  • YiPSCELL Inc.

The Description of Our Patent License Programs

Our company grants licenses for the use and application of patented inventions related to iPS cell technologies to companies involved in the development and commercialization of medical technologies and pharmaceuticals in the iPS cell space. Please see below for more information.

License